Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 814 results for "eli lilly"

Eli Lilly earning trounce forecasts

Eli Lilly's quarterly revenue plunged due to generic competition for its Cymbalta depression drug and its Evista osteoporosis treatment, but cost controls helped earnings beat forecasts. Lilly today said it had earned 68 cents per share in the ... FX Centre, 5 hours ago
Eli Lilly Tops Views, Vows to Remain Independent, 3 days ago

409 images for eli lilly

American Banking News, 3 days ago
Mideast Time, 1 week ago, 3 days ago
Bidness Etc, 3 days ago, 3 days ago, 3 days ago
Bidness Etc, 1 week ago, 3 days ago
Bio Spectrum Asia, 6 days ago
Yahoo! Finance, 1 week ago

Eli Lilly copy of $8 billion Sanofi insulin wins EU green light

European regulators have for the first time recommended approval of Eli Lilly's Abasaria, a bio-similar version of Sanofi's Lantus, which generates approximately $8 billion in yearly sales, as reported in Yahoo!7 News. The European Medicines Agency ...
 FirstWord Pharma6 hours ago Eli Lilly copy of $8 bn Sanofi insulin wins EU green light  Economic Times1 month ago

Lilly Q2 Profit Declines, But Beats View; Backs FY14 Adj. Earnings Forecast

Drug maker Eli Lilly and Co. (LLY: Quote) reported Thursday a sharp decline in second-quarter profit as revenues were hurt mainly by the impact of U.S. patent expirations for Cymbalta and Evista. Earnings per share, however, topped analysts' ...
 RTTNews.com3 days ago Lilly Profit Beats Estimates on Sales of Diabetes Drug  Bloomberg3 days ago Lilly 2Q profit falls 39 percent  Miami Herald3 days ago Eli Lilly Beats Quarterly Estimates on Diabetes Drug Sales  Washington Post3 days ago

Loss of Patents Main Cause of Lower Earnings at Eli Lilly and Co (LLY)

The loss of Patents over the years, has been the main cause of lower earnings at Eli Lilly and Co (NYSE : LLY ) , the CEO of the company, Dr. John Lechleiter, said in an interview on CNBC . The loss of Zyprexa patent in the U.S caused the company ...
 InsiderMonkey.com3 days ago Eli Lilly beats by $0.03, beats on revenue  Seeking Alpha3 days ago Will Generics Eat Into Eli Lilly's (LLY) Q2 Earnings?  Yahoo! Finance4 days ago Eli Lilly and Co Posts Lower Q2 Results; Beats Estimates (LLY)  Dividend.com3 days ago
Bidness Etc

Eli Lilly' net earnings declines by 39% in Q2

Eli Lilly and Company has received major setback during the second quarter ended June 2014 due to the impact of changes in price, foreign exchange rates and, patent expirations for Cymbalta and Evista. Its net earnings declined sharply by 39.1 per ...
 PharmaBiz2 days ago Eli Lilly Profits, Revenues Sink On Patent Expiries  Bidness Etc3 days ago Eli Lilly To Report Lower Earnings And Revenues In 2QFY14  Bidness Etc4 days ago New Study Shows Beta-Amyloid Imaging is Associated with Altered Diagnosis and Management of Alzheimer's Disease  US Society of Nuclear Medicine3 days ago

Eli Lilly's (LLY) CEO John Lechleiter on Q2 2014 Results - Earnings Call Transcript

Operator Ladies and gentlemen, thank you for standing by. Welcome to the Q 2014 earnings call. At this time, all participants are in a listen only mode. Later we will conduct a question-and-answer session. (Operator Instructions). As a reminder, ...
 Seeking Alpha2 days ago Q2 2014 Eli Lilly & Co Earnings Conference Call (Webcast)  Seeking Alpha3 days ago

Potential Eli Lilly (LLY) Trade Targets 2.73% Return

For a hedged play on Eli Lilly and Co ("LLY) MarketIntelligenceCenter.comaEUR(TM)s patented trade-picking algorithms selected a Sep. '14 $65.00 covered call for a net debit in the $63.27 area. That ...
 Individual.com2 days ago Potential Eli Lilly (LLY) Trade Has 2.51% Downside Protection  Individual.com1 week ago

Video: Inversions only a symptom of US tax problem: Eli Lilly CE...

CNBC | July 24, 2014 "The current U.S. tax system puts U.S. companies at a disadvantage," Eli Lilly Chief executive John Lechleiter said in a "Squawk Box" interview.
 NBCNews.com3 days ago CEOs to Obama Tax reform not an inversion Band-Aid  Big News Network3 days ago Top 3 Ways to Profit From the Tax Inversion M&A Craze  Investors Alley1 day ago CEOs to Obama: Tax reform, not an inversion Band-Aid  CNBC3 days ago

Lilly Eli Q2 profit plunges but still beats estimates

Lilly Eli & Co (LLY) , a leading manufacturer of pharmaceutical products, has announced a 39.19 percent plunge in profit for the quarter ended Jun. 30, 2014, due to sharp drop in sales and margins. The company earned $733.50 million or $0.68 a ...
 MyIris3 days ago

Eli Lilly Beats on Q2 Earnings & Revs, Maintains View

Eli Lilly & Company ( LLY ) reported second quarter 2014 adjusted earnings per share of 68 cents, a couple of cents above the Zacks Consensus Estimate but 41% below the year-ago earnings. Second quarter revenues fell 17% to $4.935 billion, ...
 Yahoo! Finance3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - eli lilly
Get updated on latest news & your favorite topics right in your inbox!
More     Less